Shukra Pharma.

{
  "main_header": {
    "sid": 505931,
    "name": "Shukra Pharma.",
    "stock_name": "Shukra Pharma.",
    "full_name": "Shukra Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/shukra-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "35.30",
    "chg": 1.68,
    "chgp": "5.0%",
    "dir": 1,
    "prev_price": "33.62",
    "mcapval": "1,501.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524632,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE551C01044",
    "curr_date": "May 07",
    "curr_time": "",
    "bse_nse_vol": "10.24 lacs",
    "exc_status": "Active",
    "traded_date": "May 07, 2026",
    "traded_date_str": "2026 05 07",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/shukra-pharma-505931-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Shukra Pharmaceuticals Ltd Faces Bearish Technical Shift Amid Mixed Momentum Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shukra-pharmaceuticals-ltd-faces-bearish-technical-shift-amid-mixed-momentum-signals-3973506",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ShukraPharmaceu_technicaldot_3973506.png",
        "date": "2026-05-04 08:00:54",
        "description": "Shukra Pharmaceuticals Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has recently experienced a shift in its technical momentum, moving from a mildly bearish to a bearish trend. Despite a modest day change of 0.03%, the stock’s technical indicators reveal a complex picture with mixed signals across weekly and monthly timeframes, prompting a downgrade in its Mojo Grade from Hold to Sell as of 30 April 2026."
      },
      {
        "title": "Shukra Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/shukra-pharmaceuticals-ltd-is-rated-sell-3972836",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ShukraPharmaceu_mojoScore_3972836.png",
        "date": "2026-05-03 10:10:36",
        "description": "Shukra Pharmaceuticals Ltd is rated Sell by MarketsMOJO, with this rating last updated on 30 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 May 2026, providing investors with the most up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Shukra Pharmaceuticals Drops 10.88%: 3 Key Technical Signals Driving the Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shukra-pharmaceuticals-drops-1088-3-key-technical-signals-driving-the-decline-3971792",
        "imagepath": "",
        "date": "2026-05-02 17:05:05",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>27 Apr:</strong> Stock opens at ₹31.12, down 4.60%</p>\n                    <p><strong>28 Apr:</strong> Mixed technical signals amid price momentum shift</p>\n                    <p><strong>30 Apr:</strong> Death Cross formation signals potential bearish trend</p>\n                    <p><strong>30 Apr:</strong> Technical momentum shifts amid mixed indicator signals</p>\n                    <p><strong>01 May:</strong> No trading data available, week closes at ₹29.07</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">₹32.62</div></div>\n                    <div clas..."
      },
      {
        "title": "When is the next results date for Shukra Pharmaceuticals Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-shukra-pharmaceuticals-ltd-3970814",
        "imagepath": "",
        "date": "2026-04-30 23:16:00",
        "description": "The next results date for Shukra Pharmaceuticals Ltd is scheduled for 07 May 2026...."
      },
      {
        "title": "Shukra Pharmaceuticals Ltd Forms Death Cross Signalling Potential Bearish Trend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shukra-pharmaceuticals-ltd-forms-death-cross-signalling-potential-bearish-trend-3970679",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ShukraPharmaceu_dealthcross_3970679.png",
        "date": "2026-04-30 18:00:19",
        "description": "Shukra Pharmaceuticals Ltd has recently formed a Death Cross, a significant technical indicator where the 50-day moving average (DMA) crosses below the 200-DMA. This development signals a potential shift towards a bearish trend, reflecting a deterioration in the stock’s short- to medium-term momentum and raising concerns about its near-term price trajectory."
      },
      {
        "title": "Shukra Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shukra-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3969428",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ShukraPharmaceu_technicaldot_3969428.png",
        "date": "2026-04-30 08:01:28",
        "description": "Shukra Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite a recent upgrade in its Mojo Grade from Sell to Hold, the stock’s technical indicators present a complex picture, with bearish signals dominating weekly charts while monthly indicators offer a more nuanced outlook. This article analyses the latest price momentum, key technical indicators, and the implications for investors navigating the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Shukra Pharmaceuticals Ltd Sees Mixed Technical Signals Amid Price Momentum Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shukra-pharmaceuticals-ltd-sees-mixed-technical-signals-amid-price-momentum-shift-3965536",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ShukraPharmaceu_technicaldot_3965536.png",
        "date": "2026-04-28 08:02:33",
        "description": "Shukra Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, transitioning from a mildly bullish trend to a sideways movement. Despite a recent downgrade in daily price performance, the stock’s monthly indicators suggest underlying strength, presenting a complex picture for investors navigating the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Shukra Pharmaceuticals Ltd: Technical Momentum Shifts Signal Mild Bullish Outlook Amid Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shukra-pharmaceuticals-ltd-technical-momentum-shifts-signal-mild-bullish-outlook-amid-volatility-3958367",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ShukraPharmaceu_technicaldot_3958367.png",
        "date": "2026-04-23 08:01:34",
        "description": "Shukra Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance despite a recent 4.58% decline in its share price. The company’s technical indicators present a complex picture, with weekly and monthly signals diverging across key metrics such as MACD, RSI, Bollinger Bands, and moving averages. This nuanced technical landscape warrants a detailed analysis for investors seeking clarity on the stock’s near-term prospects."
      },
      {
        "title": "Shukra Pharmaceuticals Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/shukra-pharmaceuticals-ltd-is-rated-hold-3956833",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ShukraPharmaceu_mojoScore_3956833.png",
        "date": "2026-04-22 10:10:03",
        "description": "Shukra Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 17 Jul 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 22 April 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook."
      }
    ],
    "total": 632,
    "sid": "505931",
    "stock_news_url": "https://www.marketsmojo.com/news/shukra-pharmaceuticals-505931"
  },
  "announcements": [
    {
      "caption": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A",
      "datetime": "29-Apr-2026",
      "details": "<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Shukra Pharmaceuticals Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24231GJ1993PLC019079</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>4.17</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Arpita Kabra <br/> Designation: Company Secretary and Compliance Secretary <br/> EmailId: kabraarpita10@gmail.com</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Anar Jayesh Patel <br/> Designation: Chief Financial Officer <br/> EmailId: info@shukrapharmaceuticals.com</div> </div> <div> <br/> Date: 29/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Audited Financial Result For The Quarter And Financial Year Ended On 31St March 2026 Along With The Auditors Report",
      "datetime": "29-Apr-2026",
      "details": "Shukra Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/05/2026 inter alia to consider and approve Audited financial result for the quarter and financial year ended on 31st March 2026 along with the Auditors Report",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "08-Apr-2026",
      "details": "Certificate under Reg 74(5)",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "(07 May 2026)"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Shukra Pharmaceuticals Ltd has declared <strong>1%</strong> dividend, ex-date: 18 Sep 25",
          "dt": "2025-09-18",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Shukra Pharmaceuticals Ltd has announced <strong>1:10</strong> stock split, ex-date: 21 Mar 25",
          "dt": "2025-03-21",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Shukra Pharmaceuticals Ltd has announced <strong>3:1</strong> bonus issue, ex-date: 19 Apr 24",
          "dt": "2024-04-19",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Shukra Pharmaceuticals Ltd has announced <strong>6:1</strong> rights issue, ex-date: 02 Feb 23",
          "dt": "2023-02-02",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Shukra Pharmaceuticals Ltd Faces Bearish Technical Shift Amid Mixed Momentum Signals

2026-05-04 08:00:54

Shukra Pharmaceuticals Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has recently experienced a shift in its technical momentum, moving from a mildly bearish to a bearish trend. Despite a modest day change of 0.03%, the stock’s technical indicators reveal a complex picture with mixed signals across weekly and monthly timeframes, prompting a downgrade in its Mojo Grade from Hold to Sell as of 30 April 2026.

Read full news article

Shukra Pharmaceuticals Ltd is Rated Sell

2026-05-03 10:10:36

Shukra Pharmaceuticals Ltd is rated Sell by MarketsMOJO, with this rating last updated on 30 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 May 2026, providing investors with the most up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Shukra Pharmaceuticals Drops 10.88%: 3 Key Technical Signals Driving the Decline

2026-05-02 17:05:05

Key Events This Week

27 Apr: Stock opens at ₹31.12, down 4.60%

28 Apr: Mixed technical signals amid price momentum shift

30 Apr: Death Cross formation signals potential bearish trend

30 Apr: Technical momentum shifts amid mixed indicator signals

01 May: No trading data available, week closes at ₹29.07

Week Open

₹32.62

Read full news article

When is the next results date for Shukra Pharmaceuticals Ltd?

2026-04-30 23:16:00

The next results date for Shukra Pharmaceuticals Ltd is scheduled for 07 May 2026....

Read full news article

Shukra Pharmaceuticals Ltd Forms Death Cross Signalling Potential Bearish Trend

2026-04-30 18:00:19

Shukra Pharmaceuticals Ltd has recently formed a Death Cross, a significant technical indicator where the 50-day moving average (DMA) crosses below the 200-DMA. This development signals a potential shift towards a bearish trend, reflecting a deterioration in the stock’s short- to medium-term momentum and raising concerns about its near-term price trajectory.

Read full news article

Shukra Pharmaceuticals Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-04-30 08:01:28

Shukra Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite a recent upgrade in its Mojo Grade from Sell to Hold, the stock’s technical indicators present a complex picture, with bearish signals dominating weekly charts while monthly indicators offer a more nuanced outlook. This article analyses the latest price momentum, key technical indicators, and the implications for investors navigating the Pharmaceuticals & Biotechnology sector.

Read full news article

Shukra Pharmaceuticals Ltd Sees Mixed Technical Signals Amid Price Momentum Shift

2026-04-28 08:02:33

Shukra Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, transitioning from a mildly bullish trend to a sideways movement. Despite a recent downgrade in daily price performance, the stock’s monthly indicators suggest underlying strength, presenting a complex picture for investors navigating the Pharmaceuticals & Biotechnology sector.

Read full news article

Shukra Pharmaceuticals Ltd: Technical Momentum Shifts Signal Mild Bullish Outlook Amid Volatility

2026-04-23 08:01:34

Shukra Pharmaceuticals Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance despite a recent 4.58% decline in its share price. The company’s technical indicators present a complex picture, with weekly and monthly signals diverging across key metrics such as MACD, RSI, Bollinger Bands, and moving averages. This nuanced technical landscape warrants a detailed analysis for investors seeking clarity on the stock’s near-term prospects.

Read full news article

Shukra Pharmaceuticals Ltd is Rated Hold

2026-04-22 10:10:03

Shukra Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 17 Jul 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 22 April 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

View All News